All web articles
Patient Access to Miltefosine in Developing Countries Not Secure Despite Award of US FDA Priority Review Voucher Sold for USD 125 Million
DNDi and MSF urge Knight Therapeutics, Paladin, and Endo to commit to key drug access requirements for treatment of leishmaniasis worldwide
Last updated 25 November 2014
India: MSF supports the introduction and roll-out of single-dose treatment for kala azar in Bihar State
Vaishali, Delhi, Nairobi, November 17, 2014: From this day on, treatment for kala azar will only take two hours. Single-dose liposomal amphotericin B, commonly referred to as SD LAmB, has now been made...
Last updated 17 November 2014
© Martin Zinggl/MSF
Last updated 13 November 2014
Every year, over one million children across the globe die of pneumonia and other respiratory diseases. Over the past few years, some progress has been made in improving access to life-saving vaccines...
Last updated 12 November 2014
Guinea, Photo by Julien Rey/MSF
Last updated 24 October 2014
A More Robust Response Needed Now Drug-resistant TB (DR-TB) is increasingly spreading from person to person in places around the world, with some countries reporting up to 35% of new TB cases as multi-drug...
Last updated 22 October 2014
“I can also serve as an inspiration” – a role for social media in supporting patients undergoing treatment for multidrug-resistant tuberculosis (MDR-TB)
Last updated 9 October 2014
The European Parliament Working Group (EPWG) on innovation, access to medicines and poverty-related diseases held its inaugural reception for the 2014-2019 legislature on Tuesday, 7 October 2014 with...
Last updated 7 October 2014
Mexico City/ October 1st- The 43,000 inhabitants in San Pedro Pochutla and Mazunte, Oaxaca State, Mexico, have access to diagnosis and treatment for Chagas in primary healthcare facilities. The Oaxaca...
Last updated 1 October 2014